HERON THERAPEUTICS earnings per share and revenue

AXD2 earnings per share for the last quarter are -0.02 CHF whereas the estimation was -0.07 CHF which accounts for 73.16% surprise. Företagets omsättning för samma period uppgår till 31.28 M CHF trots den uppskattade siffran 29.75 M CHF. Estimated earnings per share for the next quarter are -0.03 CHF, and revenue is expected to reach 32.43 M CHF. Also watch annual changes over time to get a bigger picture of AXD2 earnings per share and revenue dynamics.